相关实验视频

Updated: Jan 13, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

通过利用Nrf2信号传递来治疗骨关节炎,重新利用甲福明

Yeyin Zhong¹, Junyuan Chen², Nannan Shi¹

¹Division of Histology and Embryology, International Joint Laboratory for Embryonic Development & Prenatal Medicine, Medical College, Jinan University, Guangzhou, 510632, China.

Scientific reports

|January 10, 2026

概括

甲胺可以通过减少氧化应激和激活Nrf2通路来治疗骨关节炎 (OA). 这种糖尿病药物在动物模型和患者数据中显示出潜力,为OA提供了新的治疗途径.

科学领域:

生物医学科学生物医学科学
药理学药理学是指药理学的学科.
整形外科整形外科整形外科

背景情况:

骨关节炎 (OA) 是一种普遍存在的退行性关节疾病,有效治疗方法有限.
氧化应激是OA病变发生的一个关键因素.
甲福明是一种2型糖尿病药物,具有潜在的抗氧化特性.

研究的目的:

研究甲胺对骨关节炎的作用和机制.
通过向氧化应激和Nrf2信号,探索甲福明作为一种OA治疗的潜力.

主要方法:

对OA病原和氧化应激的系统审查.
在体内研究使用单酸 (MIA) 诱导的小鼠模型对OA.
在体外和体内实验中评估甲福胺对氧化应激和Nrf2表达的影响.
对Nrf2淘汰小鼠进行分析,以确认Nrf2的作用.
在2型糖尿病患者中治疗甲福明的OA进展的回顾性分析.

主要成果:

甲胺在小鼠中部分缓解了OA疼痛,并适度延迟了OA进展.
甲胺通过促进核因子红色素2相关因子2 (Nrf2) 表达来抑制氧化应激.
Nrf2 缺乏减弱了甲福胺的冠状状腺保护作用,突出了 Nrf2 的关键作用.
追溯的患者数据表明,在接受甲福林治疗的OA患者中,膝关节关节整形术的发生率较低.

结论:

甲胺减轻了OA的病理进展,主要是通过激活Nrf2信号通路.
甲胺显示出作为一种新型治疗骨关节炎的新疗剂的有前途潜力.
通过Nrf2激活准氧化应激是一种可行的OA治疗策略.

关键词:

冠状细胞 (chondrocytes) 是一种细胞.甲胺是一种甲胺.Nrf2 没有任何问题.骨关节炎是一种骨关节炎.氧化应激是一种氧化应激.

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...